Dudediligence.

Xenon Pharmaceuticals Inc

XENENASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$0.00Sep ’24$0.00Dec ’24$7.5MMar ’25$0.00Jun ’25$0.00Sep ’25$0.00Dec ’25$0.00Mar ’26$0.00Jun ’26
Net income, by quarter
−$62.8MSep ’24−$65.7MDec ’24−$65.0MMar ’25−$84.7MJun ’25−$90.9MSep ’25−$105.3MDec ’25−$102.3MMar ’26−$110.7MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$18.4M$9.4M$0.00$0.00$7.5M
Operating income−$79.0M−$129.1M−$214.1M−$279.3M−$373.1M
Net income−$78.9M−$125.4M−$182.4M−$234.3M−$345.9M
Operating cash flow−$69.5M−$101.0M−$151.1M−$181.4M−$279.1M
Free cash flow−$71.6M−$103.9M−$156.7M−$184.5M−$279.9M
Cash$175.7M$57.2M$148.6M$142.7M$199.2M
Shares outstanding51.6M62.6M75.4M76.4M80.0M